How to get your Nerivio device from your VA Healthcare Provider
Make an appointment with your VA Healthcare Provider. You may be required to get a referral to your closest VA neurologist
Print and share your Migraine Discussion Guide with your VA Healthcare Provider
Your Nerivio device will be available either at your VA or mailed to your home
Upon receiving your Nerivio, click here to learn more
*If not enrolled in the VA system contact by visiting www.va.gov/healthbenefits/enroll or by calling 1-877-222-VETS (1-877-222-8387)
Drug-free, easy-to-use, non-invasive device for the acute treatment of migraine
Text NERIVIO to 866-637-4846 to receive the Nerivio App.
For assistance activating your device or for any technical questions contact Nerivio Cares Customer Support at 1-937-NERIVIO (937-637-4846) or support@stg.nerivio.comm
Nerivio is indicated for migraine patients 12 years of age or older. Nerivio should not be used by people with congestive heart failure, severe cardiac or cerebrovascular disease, or uncontrolled epilepsy. Nerivio should not be used by anyone with active implantable medical devices (eg, pacemaker, hearing aid implant). It should only be applied on the upper arm over dry, healthy skin with normal physical sensation and without any metallic implants or in proximity to cancerous lesions. Nerivio has not been evaluated in pregnancy or those under the age of 12.
-
- https://americanmigrainefoundation.org/resource-library/veterans-and-migraine/
- GBD 2016 Headache Collaborators. Global, regional, and national burden of migraine and tension-type headache, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol. 2018;17(11):954-976. doi:10.1016/S1474-4422(18)30322-3
- Yarnitsky D, Dodick DW, Grosberg BM, Burstein R, Ilroni A, Harris D, Lin T, Silberstein SD. Remote Electrical Neuromodulation (REN) Relieves Acute Migraine: A Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial. Headache. 2019;59(8): 1240-1252
- Marmura MJ, Lin T, Harris D, lroni A, Rosen NL. Incorporating Remote Electrical Neuromodulation (REN) Into Usual Care Reduces Acute Migraine Medication. Use: An Open-Label Extension Study. Frontiers in Neurology. 2020; 11 :226